A look back on London EdTech Week 2024; exclusive insights from Gold Sponsor, Goodnotes, & Silver Sponsor, Datasite; and IBIS Capital Analyst, Sophia Nasser, considers if GLP-1 agonists are a miracle cure in tackling global obesity.
Plus, market roundups & industry analyses across EdTech & HealthTech.
Read the July 2024 edition here
IBIS Capital’s latest industry research report includes a 60-page deep dive into the management of chronic diseases and the innovative digital health businesses enabling the healthcare industry’s evolution. The report analyses 2,900+ digital health companies across 3 segments (Patient-Facing Digital Solutions, Health Care at Home, Provider Solutions) and includes data from 5,500+ transactions. We discuss M&A and fundraising trends, business models, public market dynamics and investment outlook.
Submit your details here for free access to the report.
At last month’s HealthTechX Summit, Dr. Vishaal Virani, MBBS, Head of Health at YouTube UK & Ireland joined Shubs Upadhyay, Director of Medical Quality at Ada Health for an engaging fireside chat on leveraging technology to bridge the gap between efficacy and access in healthcare.
The discussion highlighted the potential of healthtech platforms to reconcile the efficacy and access axes in healthcare delivery. By harnessing technology to disseminate high-quality information, healthcare systems can empower patients to make informed decisions while alleviating strain on resources.
Read more about how technology can help healthcare systems create solutions for chronically ill patients which are both effective and widely accessible here.
From Olympic glory to FemTech entrepreneurship, Dame Jessica Ennis-Hill shares her insights and experiences with a powerful message of determination, resilience, and the transformative power of health technology.
Read the full article here.
The winners of IBIS Capital’s 2024 HealthTechX Awards were revealed on stage at the HealthTechX Summit on 28th February. Celebrating innovation, impact and growth, the awards recognise companies that are using technology to advance healthcare and support patients, providers, payers, and pharma in delivering more efficient care for better outcomes.
Read the full article here.
In the wake of the toughest funding market in 5 years, IBIS Capital CEO, Charles McIntyre anticipates a cautious recovery in 2024 demanding optimism amid geopolitical uncertainties.
Plus, market roundups & industry analyses across EdTech & HealthTech.
Read the January 2024 edition here.
Dr Michelle Tempest and Marc Kitten, both Partners at healthcare and life sciences consultancy Candesic, explore the excitement around Digital therapeutics (DTx) as an emerging field in healthcare. DTx use technology to deliver evidence-based interventions to treat, manage, or prevent diseases. This article examines the current state of DTx in Europe, its challenges and opportunities, and the implications for healthcare providers, policymakers, and investors.
Read the full article here.
Coverage on STEM education for sustainability and trends that have redefined the healthtech investment landscape.
Plus, AI in clinical trial protocol design, the future beyond conventional AI, market roundups & industry analyses across EdTech & HealthTech.
Read the September 2023 edition here.
A roundup of the 2023 EdTechX Summit, and a venture capital perspective on AI in Healthcare. Plus, news on the EdTechX Award Winners, how a gynaecological health platform is tackling the gender pain and diagnostics gap, market roundups & Q2 industry analyses across EdTech & HealthTech.
Read the June-July edition here.
Valentina Milanova, Founder of Daye, joins IBIS Capital Vice President, Bracy Fertig, in an enlightening conversation about her mission to bridge the gender gap in medical research and innovation, specifically for gender pain and diagnostics. A gynaecological health platform, Daye, repurposes menstrual tampons for pain relief and at-home gynaecological diagnostics by investing in R&D to create truly sustainable products that not only impact their consumers, but also the planet. Learn about the company’s strategy to achieve this and their plans to impact other areas of gynaecological health in the future.
Regulated by the Financial Conduct Authority.
Copyright © 2022 IBIS Capital Limited. All Rights Reserved.
